• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AstraZeneca Forms Health Tech Business, Evinova to Deliver Digital Health Solutions for Life Sciences

by Jasmine Pennic 11/21/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– AstraZeneca, a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals, regulators, and patients.

– With long-term support from AstraZeneca and strategic partnerships with Parexel and Fortrea, Evinova aims to become a leading provider of globally-scaled digital products and services for the life sciences and healthcare sector.

Digital Solutions for Clinical Trials

Evinova’s initial focus will be on bringing established and scaled digital technology solutions to market, leveraging AstraZeneca’s proven expertise in optimizing clinical trial design and delivery. These solutions have already demonstrated their effectiveness in reducing the time and cost of developing new medicines, bringing care closer to home for patients, and alleviating the burden on healthcare systems.

Expansion into Remote Patient Monitoring and Digital Therapeutics

Evinova will also pursue opportunities in digital remote patient monitoring and digital therapeutics, with a pipeline of innovative solutions in these areas. Drawing on AstraZeneca’s deep experience in developing novel therapeutics and insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech, and CROs to support clinical research globally.

Partnership with Parexel and Fortrea

Evinova’s success is built on collaboration. Globally leading CROs Parexel and Fortrea have entered into agreements to offer Evinova’s digital health solutions to their extensive customer base. Additionally, Evinova is partnering with Accenture and Amazon Web Services to accelerate industry adoption and expand the global reach of its digital products.

Pascal Soriot, Chief Executive Officer of AstraZeneca, expressed his optimism about the future of medicine and the role of digital solutions. He stated, “The future of medicine development can be accelerated with digital solutions. We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale provides a real opportunity to fundamentally improve patient care, drive healthcare transformation, and reduce carbon emissions.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AstraZeneca

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |